$4.62 -0.12 (-2.59%)

Evoke Pharma, Inc. (EVOK)

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing treatments for rare and underserved diseases. Its primary product is Gimoti, an oral solution for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company aims to address unmet medical needs through innovative drug formulations and targeted therapies.

🚫 Evoke Pharma, Inc. does not pay dividends

Company News

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
GlobeNewswire Inc. • Daniel Kontoh-Boateng • August 26, 2025

Evoke Pharma partnered with EVERSANA and Omnicell to expand access to GIMOTI nasal spray for gastroparesis treatment, targeting large gastroenterology practices and specialty pharmacies through strategic pharmacy network agreements.

Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga • Avi Kapoor • January 12, 2024

Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares jumped 16.7% to $6.27 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Charge Enterprises, Inc. (NASDAQ: CRGE) shares...

Biotech Penny Stocks Investing Guide
PennyStocks • J. Phillip • June 20, 2022

What to know about trading biotech stocks in 2022 The post Biotech Penny Stocks Investing Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.